Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

TMK to place 40 mln additional shares

12/7/23 TRMK

Moscow Exchange conducted the first deal with DFA on the secondary market

12/7/23 MOEX

Abrau-Durso launches a new project in Moscow - Abrau Club

12/7/23 ABRD

Etalon renews sales record

12/7/23 ETLN

PIK places debut CFA on an apartment

12/7/23 PIKK

New head of NLMK will be Sergey Karataeva from PGK

12/7/23 NLMK

Softline completed SPO and found another institutional investor

12/7/23 SOFL

Mosgorlombard began collecting applications for participation in the IPO

12/7/23 MGKL

VTB plans to increase its office network by 40% in three years

12/7/23 VTBR

Owners of 73.3% of HeadHunter agreed to exchange receipts for shares

12/7/23 HEAD